STrong Relationships to Improve DiabEtes Pilot
- Conditions
- Type 2 Diabetes
- Registration Number
- NCT07210593
- Lead Sponsor
- Vanderbilt University Medical Center
- Brief Summary
This is a pilot and feasibility study for a mobile phone-delivered intervention, called STRIDE (STrong Relationships to Improve DiabEtes), designed to provide support for adults with type 2 diabetes (improve glycemic management and social support). The goal of the study is to examine the feasibility and acceptability of STRIDE.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 180
PERSONS WITH DIABETES:
- Speaks and reads in English
- 18-75 years old
- Diagnosed with type 2 diabetes
- Receiving outpatient care from a partnering clinic
- Community-dwelling (e.g., not in a nursing facility)
- Prescribed at least one daily diabetes medication
- Owns a mobile phone
- Elevated diabetes distress or low diabetes self-efficacy
- Willing to invite a close friend or family member to co-participate
SUPPORT PERSONS:
- Speaks and reads in English
- 18 years or older
- Owns a mobile phone
PERSONS WITH DIABETES
- Unable to communicate by phone
- Currently pregnant
- Currently undergoing treatment for cancer (e.g., radiation, chemotherapy)
- Diagnosed with end-stage renal disease
- Receiving hospice services
- Diagnosed with congestive heart failure
- Diagnosed with dementia
- Diagnosed with schizophrenia
- Demonstrated an inability to receive and respond to a text
- Does not take medication on his/her own/medication administered by someone else SUPPORT PERSONS
- Demonstrated inability to receive & respond to a text
- Unable to communicate by phone
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Primary Outcome Measures
Name Time Method Acceptability 6 months post-baseline Net Promoter Score with scores ranging 0 to 100 where higher scores (scaled score \>0) indicate good acceptability
Feasibility (Recruitment) baseline Proportion of eligible screens who enroll
Feasibility (Treatment Adherence) 6 months post-baseline Proportion of interactive texts with response
Feasibility (Assessment Completion) 3 and 6 months post-baseline Proportion of self-report measures completed
- Secondary Outcome Measures
Name Time Method Change in Hemoglobin A1c Baseline and 3 and 6 months post-baseline Hemoglobin A1c assessed by mail-in A1c kits from BioQuintex and/or taken from electronic health record (venipuncture or point-of-care) where higher values indicate worse glycemic management
Change in Diabetes Distress Baseline and 3 and 6 months post-baseline Assessed by the Problem Areas in Diabetes (PAID-5) with scores ranging 0-100 where higher scores indicate more emotional, psychological and social distress related to diabetes management (worse)
Change in Psychosocial Well-being Baseline and 3 and 6 months post-baseline Assessed by the World Health Organization - Five Well-Being Index (WHO-5) with scores ranging 0 to 100 where higher scores indicate more well-being (better)
Change in Social Support for Diabetes Baseline and 3 and 6 months post-baseline Assessed by the Diabetes Support Scale (DSS) with scores ranging 12 to 84 where higher scores indicate more social support for diabetes (better)
Trial Locations
- Locations (1)
Vanderbilt University Medical Center
🇺🇸Nashville, Tennessee, United States
Vanderbilt University Medical Center🇺🇸Nashville, Tennessee, United StatesMcKenzie K Roddy, PhDContactSTRIDE@vumc.org